Skip to main content
. 2018 Oct 31;5(11):ofy280. doi: 10.1093/ofid/ofy280

Table 2.

Isolate Susceptibilitiesa

Drug tested, %Susceptible (n/N Tested)
AMK ATM FEP/CAZ GEN MEM/IPM TZP TOB CST
78.6%
(125 of 159)
7.2%
(10 of 139)
14.4%
(21 of 177)
57.7%
(94 of 163)
3.4%
(6 of 179)
5.8%
(10 of 173)
74.3%
(104 of 140)
91.9%
(57 of 62)
Ceftolozane-tazobactam (n/N tested, % susceptible) 125 of 139 (89.9%)

Abbreviations: AMK, amikacin; ATM, aztreonam; CAZ, ceftazidime; CST, colistin; FEP, cefepime; GEN, gentamicin; IPM, imipenem; MEM, meropenem; TOB, tobramycin; TZP, piperacillin-tazobactam.

aMost centers reported results for either FEP or CAZ and MEM or IPM. Results here reflect the combined data for both. Not all centers tested all listed drugs.